α-synuclein filaments bind the transcriptional regulator HMGB-1

NeuroReport

Volumn 15, Issue 18, 2004, Pages 2735-2739

  Lindersson, Evo K ^a   Højrup, Peter ^b   Gai, Wei Ping ^c   Locker, Daniel ^d   Martin, Davy ^d   Jensen, Poul Henning ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d UNIVERSITÉ D'ORLÉANS   (France)

Author keywords

Synuclein; Filaments; HMGB 1; Lewy body; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; CELL PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; LIGAND;

ARTICLE; BRAIN TISSUE; DEMENTIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LEWY BODY; MASS SPECTROMETRY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; TRANSCRIPTION REGULATION;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; HMGB1 PROTEIN; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IODINE ISOTOPES; LEWY BODIES; LEWY BODY DISEASE; LIGANDS; MICROSCOPY, IMMUNOELECTRON; NERVE TISSUE PROTEINS; NEURITES; NEURONS; PARKINSON DISEASE; PEPTIDE MAPPING; PROTEIN BINDING; RATS; RECOMBINANT PROTEINS; SYNUCLEINS;

EID: 11244258633     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lindersson E, Beedholm R, Højrup P, Moos T, Gai WP, Hendil KB and Jensen PH. Proteasomal inhibition by α-synuclein filaments and oligomers. J Biol Chem 2004; 279:12924-12934.
2. Iwata A, Miura S, Kanazawa I, Sawada M and Nukina N. Alpha-synuclein forms a complex with transcription factor Elk-1. J Neurochem 2001; 77:239-252.
3. Togo T, Iseki E, Marui W, Akiyama H, Ueda K and Kosaka K. Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies. J Neurol Sci 2001; 184:71-75.
4. Jensen PH, Islam K, Kenney J, Nielsen MS, Power J et al. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments. J Biol Chem 2000; 275: 21500-21507.
5. Bustin M and Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996; 54:35-100.
6. Boonyaratanakornkit V, Melvin V, Prendergast P, Altmann M, Ronfani L, Bianchi ME et al. High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 1998; 18:4471-4487.
7. Locker D, Decoville M, Maurizot JC, Bianchi ME and Leng M. Interaction between cisplatin-modified DNA and the HMG boxes of HMG 1: DNase I footprinting and circular dichroism. J Mol Biol 1995; 246:243-247.
8. Shevchenko A, Wilm M, Vorm O, Jensen ON, Podtelejnikov AV, Neubauer G et al. A strategy for identifying gel-separated proteins in sequence databases by MS alone. Biochem Soc Trans 1996; 24:893-896.
9. Kalume DE, Kieffer S, Rafn K, Skou L, Andersen SO and Roepstorff P. Sequence determination of three cuticular proteins and isoforms from the migratory locust, Locusta migratoria, using a combination of Edman degradation and mass spectrometric techniques. Biochim Biophys Acta 2003; 1645:152-163.
10. Peri S, Steen H and Pandey A. GPMAW - a software tool for analyzing proteins and peptides. Trends Biochem Sci 2001; 26:687-689.
11. Janke C, Martin D, Giraud-Panis MJ, Decoville M and Locker D. Drosophila DSP1 and rat HMGB1 have equivalent DNA binding properties and share a similar secondary fold. J Biochem 2003; 133: 533-539.
12. Gai WP, Yuan HX, Li XQ, Power JT, Blumbergs PC and Jensen PH. In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 2000; 166:324-333.
13. Lin WL, DeLucia MW and Dickson DW. Alpha-synuclein immunoreactivity in neuronal nuclear inclusions and neurites in multiple system atrophy. Neurosci Lett 2004; 354:99-102.
14. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277:1990-1993.
15. Cha JHJ. Transcriptional dysregulation in Huntington's disease. Trends Neurosci 2000; 23:387-392.
16. Dhandapani KM and Brann DW. Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 2002; 67:1379-1385.
17. Verrijdt G, Haelens A, Schoenmakers E, Rombauts W and Claessens F. Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem J 2002; 361:97-103.
18. Melvin VS, Roemer SC, Churchill ME and Edwards DP. The C-terminal extension (CTE) of the nuclear hormone receptor DNA binding domain determines interactions and functional response to the HMGB-1/-2 co-regulatory proteins. J Biol Chem 2002; 277: 25115-25124.
19. Calogero S, Grassi F, Aguzzi A, Voigtlander T, Ferrier P, Ferrari S and Bianchi MP. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nature Genet 1999; 22:276-280.